CN102219811B - Ca-4衍生物、其制法及其医药用途 - Google Patents
Ca-4衍生物、其制法及其医药用途 Download PDFInfo
- Publication number
- CN102219811B CN102219811B CN 201110093276 CN201110093276A CN102219811B CN 102219811 B CN102219811 B CN 102219811B CN 201110093276 CN201110093276 CN 201110093276 CN 201110093276 A CN201110093276 A CN 201110093276A CN 102219811 B CN102219811 B CN 102219811B
- Authority
- CN
- China
- Prior art keywords
- deoxidation
- methoxyl group
- arh
- phenoxy group
- och
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110093276 CN102219811B (zh) | 2011-04-14 | 2011-04-14 | Ca-4衍生物、其制法及其医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110093276 CN102219811B (zh) | 2011-04-14 | 2011-04-14 | Ca-4衍生物、其制法及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102219811A CN102219811A (zh) | 2011-10-19 |
CN102219811B true CN102219811B (zh) | 2013-07-03 |
Family
ID=44776538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110093276 Active CN102219811B (zh) | 2011-04-14 | 2011-04-14 | Ca-4衍生物、其制法及其医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102219811B (it) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103288605B (zh) * | 2013-06-06 | 2015-04-08 | 陕西师范大学 | 考布他丁的合成方法 |
CN103421057B (zh) * | 2013-08-14 | 2016-03-30 | 合肥医工医药有限公司 | 康普瑞汀氨基糖缀合物、其制法及其医药用途 |
CN104817519B (zh) * | 2015-05-11 | 2016-11-16 | 中国药科大学 | 一类ca-4的衍生物、其制法及其医药用途 |
CN106727629A (zh) * | 2016-12-16 | 2017-05-31 | 中国药科大学 | 一种来源考布他汀a‑4衍生物的抗肿瘤机制研究 |
CN115403483B (zh) * | 2021-07-02 | 2024-01-26 | 河南省儿童医院郑州儿童医院 | 含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用 |
CN115887687A (zh) * | 2022-11-23 | 2023-04-04 | 广东省科学院动物研究所 | 一种透明质酸(ha)-ca-4偶联物及其合成方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005682A1 (en) * | 1992-08-31 | 1994-03-17 | Francesca Pelizzoni | Combretastatin derivatives with antitumoral activity and process for the preparation thereof |
CN101591369A (zh) * | 2008-05-30 | 2009-12-02 | 徐云根 | N-糖基-3-芳基丙烯酰胺衍生物、其制法及其医药用途 |
-
2011
- 2011-04-14 CN CN 201110093276 patent/CN102219811B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005682A1 (en) * | 1992-08-31 | 1994-03-17 | Francesca Pelizzoni | Combretastatin derivatives with antitumoral activity and process for the preparation thereof |
CN101591369A (zh) * | 2008-05-30 | 2009-12-02 | 徐云根 | N-糖基-3-芳基丙烯酰胺衍生物、其制法及其医药用途 |
Non-Patent Citations (7)
Title |
---|
Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs;Pettit, George R.等;《Anti-Cancer Drug Design》;19951231;第10卷;全文 * |
Brown R. T. 等.Synthesis of Water-soluble Sugar Derivatives of Combretastatin A-4.《Journal of the Chemical Society. Perkin transactions. I》.1995,第577-581页. |
Pettit, George R.等.Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs.《Anti-Cancer Drug Design》.1995,第10卷第299-309页. |
Synthesis of Water-soluble Sugar Derivatives of Combretastatin A-4;Brown R. T. 等;《Journal of the Chemical Society. Perkin transactions. I》;19950101;全文 * |
曲峰,等.氢化可的松氨基糖衍生物的合成.《有机化学》.2003,第23卷(第4期),第361-367页. |
李林鲜,等.风车子抑素A4及其衍生物的研究进展.《国际药学研究杂志》.2009,第36卷(第1期),第48-53页. * |
氢化可的松氨基糖衍生物的合成;曲峰,等;《有机化学》;20030425;第23卷(第4期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN102219811A (zh) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102219811B (zh) | Ca-4衍生物、其制法及其医药用途 | |
CN110291065A (zh) | 一种新的异二氢吲哚衍生物、其药物组合物及应用 | |
CN104080455A (zh) | 某些化学实体、组合物及方法 | |
JP2014525443A (ja) | キヌレニン−3−モノオキシゲナーゼインヒビター、医薬組成物、およびこれらの使用方法 | |
CN104053442A (zh) | 某些化学实体、组合物及方法 | |
TWI706951B (zh) | 一種週期素依賴性蛋白激酶抑制劑的羥乙基磺酸鹽、其結晶形式及製備方法 | |
CN103421061A (zh) | 来那度胺衍生物、其制法及其医药用途 | |
CN101624376B (zh) | 取代酰肼类化合物及其应用 | |
CN103044395B (zh) | 含有地氯雷他定结构的氨基酸类衍生物、其制备方法和用途 | |
KR20170106294A (ko) | Dpp-4 억제제인 벤조 6원 고리 유도체 및 이의 응용 | |
CN113784963A (zh) | 用作ret激酶抑制剂的化合物及其应用 | |
CN104837844A (zh) | 作为酪蛋白激酶1 d/e抑制剂的吡唑取代的咪唑并哌嗪 | |
CN115417788A (zh) | 一种抗炎化合物及其制备方法和用途 | |
CN103421057B (zh) | 康普瑞汀氨基糖缀合物、其制法及其医药用途 | |
CN103748060B (zh) | 1,3-二氧代茚衍生物、其药学上可接受的盐或光学异构体,其制备方法以及包含其作为抗病毒活性成分的药物组合物 | |
CN108299420A (zh) | 作为选择性雌激素受体下调剂的五环类化合物及其应用 | |
KR102394934B1 (ko) | Akt 억제제로서의 염 형태 및 이의 결정 형태 | |
CN110294742B (zh) | 并环类ask1抑制剂及其应用 | |
CN101591364B (zh) | 氨基糖衍生物、其制法及其医药用途 | |
CN101928323B (zh) | 3,23,28位修饰的23-羟基白桦酸类衍生物、其制备方法、制剂及用途 | |
CN104098524B (zh) | 1-间甲氧基苯甲酰基-3-苯基-1,4-二氢-1,2,4,5-四嗪及制备和应用 | |
CN104586842A (zh) | 一种抗癌活性吲哚衍生物、合成方法及其用途 | |
CN110092789B (zh) | 一种吲哚并[2,3-b]咔唑衍生物及其应用 | |
CN104211699A (zh) | β-咔啉衍生物,其制备,纳米结构,抗肿瘤活性和应用 | |
Ishimoto et al. | Convergent and streamlined synthesis of 6-etherified imidazo [1, 2-b] pyridazine-2-amine derivatives possessing VEGFR-2 kinase inhibitory activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Nanjing City, Jiangsu Province, Tong Lane 210009 No. 24 Co-patentee after: Hefei Medical and Pharmaceutical Co., Ltd. Patentee after: China Pharmaceutical University Address before: Nanjing City, Jiangsu Province, Tong Lane 210009 No. 24 Co-patentee before: Hefei Yigong Medicine Co., Ltd. Patentee before: China Pharmaceutical University |
|
CP01 | Change in the name or title of a patent holder |